Skip To Main Content
Amanda Chu on Muck Rack

Amanda Chu

Verified
East Coast United States
As seen in: POLITICO, MSN, MSN UK, UOL, Financial Times, Die Welt, Yahoo Finance, Ars Technica, Digital Future Daily, Milenio, Taylor & Francis Online and
Health reporter @politico | previously @FT | Queens native | Send tips on Signal: amandachu.95 | Email: achu@politico.com

Get in touch with Amanda

Contact Amanda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Cassidy's career-defining vote

|
By Amanda Chu Verified, Sophie Gardner Verified
| POLITICO Verified
CASSIDY'S LEGACY-DEFINING MOMENT — Senate Health Committee Chair Bill Cassidy (R-La) will face one of his final defining moments in office today when he decides whether to vote to advance Erica Schwartz , President Donald Trump 's pick to helm the Centers for Disease Control and Prevention, Sophie reports. The Louisiana senator entered Trump's crosshairs when he voted to convict the president for his role in the Jan. 6, 2021, Capitol riot.
Open in Who Shared Issue with article?

‘The innocent are paying for it’: Fraud investigations put Minnesota’s care economy in crisis

|
By Amanda Chu Verified, Robert King
| Yahoo Verified
BARNUM, Minnesota — Looking across her farm in rural Minnesota, Heather Wright takes stock of what she's lost. Six months ago, she had a herd of 60 cattle and a full staff on her farm providing therapy for children with autism. Those cows have since been sold off, along with company cars, and several employees have left for steadier jobs at a convenience store.
Open in Who Shared View Duplicates (2) Issue with article?

It’s complicated: the Trump-pharma relationship split by the Atlantic

|
By Caroline Hug Verified, Amanda Chu Verified
| POLITICO Europe Verified
U.S. President Donald Trump's administration and the pharmaceutical sector may be at war over drug prices in Washington. But in Europe, they’re working in partnership to drive them up. Pharmaceutical companies are aggressively lobbying U.S. trade officials to open new tariff investigations into European countries with tightly controlled medicine prices, according to five people familiar with the administration’s thinking.
Open in Who Shared Issue with article?
See all 747 licensed articles (774 Total)